by In2Pharma | Oct 1, 2025 | News
The Netherlands On July 1st, 2025, the NPS (New Psychoactive Substances) legislative amendment came into force, adding list IA to the Opium Act. The amendment is aimed at combating New Psychoactive Substances and to take more effective actions against designer drugs...
by In2Pharma | Sep 26, 2025 | News
Europe Health claims for food supplements are strictly regulated. For supplements containing plant extracts (botanicals), most claims fall under the so-called on-hold regulation. This means that the EFSA (European Food Safety Authority) has not yet issued a final...
by In2Pharma | Sep 19, 2025 | News
The Netherlands The Medicines Evaluation Board (MEB/CBG) has published an updated version of the policy document MEB45 (National implementation of additional risk minimisation measures) – version July 2025. Key changes include: – For digital materials, such as...
by In2Pharma | Nov 8, 2017 | News
The new EudraVigilance system will become operational on 22 November 2017. In order to implement this new system, the current EudraVigilance system is unavailable as of today (8 November 2017), 1.00 a.m. (Brussels time) until 22 November 2017, 10.00 a.m. (Brussels...
